MedPath

A clinical trial to study the effect of a drug shadangapaniya and hot water along with kapalbhati in patients with high cholesterol and triglyceride

Not yet recruiting
Conditions
Hyperlipidemia, unspecified,
Registration Number
CTRI/2020/07/026558
Lead Sponsor
UCA Dsrrau jodhpur karwar
Brief Summary

A randomized parallel active control trial of 45 patients in which 15 patients will be given Shadangpaniya (when patient feel thirst/As per thirst) along with Kapalbhati (3 rounds of 30 repititions, twice a day) for 45 days. 15 patients of dyslipidemia will be given ushnodaka  in the quantity of 3 litters (as per thirst) along with kapalbhati(3 rounds of 30 repititions, twice a day) for 45 days  and 15 patients will be treated with yogik kriya kapalbhati for 45 days

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

Adults of either sex 30-60 years of age Patients with a diagnosis of non-familial hypercholesterolemia or mixed dyslipidemia as one of the following Triglycerides between 150 mg/dl -500 mg/dl Cholesterol between 160 mg/dl-250 mg/dl LDL-C > 130 mg/dl.

Exclusion Criteria

Children and adolescents with any of the following Known dyslipidemia Diagnosis associated with secondary dyslipidemia Established family history of Familial Hypercholesterolemia Monogenic dyslipidemia other than Familial Hypercholesterolemia Multifactorial dyslipidemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in the sign and symptoms of patients1 month 15 days
Secondary Outcome Measures
NameTimeMethod
Efficacy of treatment1 month 15 days

Trial Locations

Locations (1)

Hospital of university college of ayurveda

🇮🇳

Jodhpur, RAJASTHAN, India

Hospital of university college of ayurveda
🇮🇳Jodhpur, RAJASTHAN, India
Dr Pramod kumar mishra
Principal investigator
9001009793
drpramodmishra4@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.